Related Experiment Videos
Intensity-modulated radiation therapy use in the U.S., 2004
Loren K Mell1, Amit K Mehrotra, Arno J Mundt
1Department of Radiation and Cellular Oncology, University of Chicago, IL 60637, USA. lmell@radonc.chicago.edu
Cancer
|August 4, 2005
Summary
Intensity-modulated radiation therapy (IMRT) use significantly increased among US radiation oncologists from 2002 to 2004. Key drivers for adoption include normal tissue sparing and dose escalation, with further growth anticipated.
Area of Science:
- Radiation Oncology
- Medical Physics
- Cancer Treatment Technology
Background:
- Intensity-modulated radiation therapy (IMRT) represents an advanced method for radiation delivery.
- Despite its novelty, comprehensive data on IMRT's risks and benefits remain limited.
Purpose of the Study:
- To assess the adoption trends of IMRT among radiation oncologists in the U.S.
- To identify the primary reasons for IMRT adoption and non-adoption.
- To compare IMRT utilization between 2002 and 2004.
Main Methods:
- A random sample of U.S. radiation oncologists was surveyed in 2002 and again in 2004.
- Physicians were questioned about their IMRT usage, clinical applications, and motivations.
- Responses from both survey years were compared to identify changes in IMRT adoption.
Main Results:
- IMRT use rose from 32.0% in 2002 to 73.2% in 2004.
- Significant adoption by nonusers (62.7%) and plans for future adoption (91%) were observed.
- Primary adoption reasons included normal tissue sparing (88.0%), dose escalation (85.1%), and economic factors (62.4%).
Conclusions:
- IMRT utilization has markedly increased among U.S. radiation oncologists.
- There is a clear need for standardized guidelines and prospective studies to evaluate IMRT's risks and benefits.